CellFitProject Workshop: Enabling Technologies & Accelerating Research to Improve T cells to Fight Cancer

Join this workshop and hear from experts and CellFit project partners as they address one of the biggest challenges for cell-based cancer therapy - efficient and scalable production. Established in 2021, this project is funded by The Research Council of Norway, a project led by Oslo University Hospital with project partners Oslo Cancer Cluster, SINTEF, and Thermo Fisher Scientific.

Agenda
14:00 REGISTRATION & COFFEE
14:10–14:20 Welcome & The CellFit Project, A Status Update
Else Marit Inderberg, PhD, Unit Leader, Translational Research Unit, Section for Cell Therapy, Department of Oncology, Oslo University Hospital

14:20–14:40 High-throughput screening to identify compounds that affect the T-cell subtype during expansion
Hanne Haslene-Hox, PhD, Senior Research Scientist, SINTEF

14:40–15:00 How to generate less differentiated, more persistent CAR T cells
Léa Rosselle, PhD, Translational Research Unit, Section for Cell Therapy, Department of Oncology, Oslo University Hospital

15:00–15:20 A streamlined automated solution for CAR-T Manufacturing using CTS™ Detachable Dynabeads™
Maxi-Lu Böschen, Scientist III R&D Cell Therapy, Thermo Fisher Scientific

15:20 - 15:40 Support functions available at the ACT Centre
Anna Pasetto, Director of the Center for Advanced Cell Therapy (ACT), Section for Cell Therapy, Division for Cancer Treatment, Cancer Clinic, Oslo University Hospital, Associate Professor, Institute of Clinical Medicine, Division of Cancer Medicine, University of Oslo

15:40-15:45 Next steps and a way forward - Closing Remarks
Else Marit Inderberg, PhD, Unit Leader, Translational Research Unit, Section for Cell Therapy, Department of Oncology, Oslo University Hospital